Clinical Trial Update: Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing cetuximab with mitomycin-C and 5-fluorouracil for locally advanced head and neck squamous cell carcinomas was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Neoplasms

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Head and Neck Neoplasms | Phase 4 | Status: TERMINATED